Literature DB >> 35544190

Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting.

Sina Nikayin1, Taeho Greg Rhee1, Maria Elena Cunningham2, Christina A de Fontnouvelle3, Robert B Ostroff1, Gerard Sanacora1, Samuel T Wilkinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35544190      PMCID： PMC9096687          DOI： 10.1001/jamapsychiatry.2022.1074

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   25.911


× No keyword cloud information.
  6 in total

Review 1.  The cost of dichotomising continuous variables.

Authors:  Douglas G Altman; Patrick Royston
Journal:  BMJ       Date:  2006-05-06

2.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

3.  Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review.

Authors:  Hitoshi Sakurai; Felipe Jain; Simmie Foster; Paola Pedrelli; David Mischoulon; Maurizio Fava; Cristina Cusin
Journal:  J Affect Disord       Date:  2020-07-20       Impact factor: 4.839

4.  A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings.

Authors:  L Alison McInnes; Jimmy J Qian; Rishab S Gargeya; Charles DeBattista; Boris D Heifets
Journal:  J Affect Disord       Date:  2022-01-11       Impact factor: 6.533

5.  Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.

Authors:  Fernanda S Correia-Melo; Gustavo C Leal; Flávia Vieira; Ana Paula Jesus-Nunes; Rodrigo P Mello; Guilherme Magnavita; Ana Teresa Caliman-Fontes; Mariana V F Echegaray; Igor D Bandeira; Samantha S Silva; Diogo E Cavalcanti; Lucas Araújo-de-Freitas; Luciana M Sarin; Marco A Tuena; Carolina Nakahira; Aline S Sampaio; José A Del-Porto; Gustavo Turecki; Colleen Loo; Acioly L T Lacerda; Lucas C Quarantini
Journal:  J Affect Disord       Date:  2019-11-14       Impact factor: 6.533

Review 6.  Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.

Authors:  Anees Bahji; Gustavo H Vazquez; Carlos A Zarate
Journal:  J Affect Disord       Date:  2020-09-23       Impact factor: 4.839
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.